Invariance of a recovery capital scale across gender, ethnicity, and sexual orientation in a substance use disorder treatment program.


Journal

The American journal of drug and alcohol abuse
ISSN: 1097-9891
Titre abrégé: Am J Drug Alcohol Abuse
Pays: England
ID NLM: 7502510

Informations de publication

Date de publication:
2019
Historique:
pubmed: 23 1 2019
medline: 15 5 2020
entrez: 23 1 2019
Statut: ppublish

Résumé

Behavioral health care providers aim to see their clients achieve lifelong recovery from substance use disorders (SUDs). To do so, they must accurately assess incoming resources and barriers to recovery to identify areas of need for their clients. A recovery capital scale (RCS) is one way to identify these resources and barriers. However, there is limited evidence that RCSs are invariant across different demographics. To evaluate whether a short 10-item RCS (SRCS-10) is invariant across gender (male versus female), ethnicity (white versus African American, Hispanic, and other racial identities) and sexual orientation (heterosexual versus non-heterosexual). The SRCS-10 is a shortened version of White's original unpublished 35-item RCS scale that was matched on items similar to the Brief Assessment of Recovery Capital (BARC-10). We used confirmatory factor analysis (CFA) to confirm unidimensionality and then conducted measurement invariance tests. This study included 2751 females (67%) and 1341 males (33%) totaling 4092 clients from six large residential treatment centers. Using both exploratory factor analysis (EFA) and CFA the SRCS-10 has a large first to second eigenvalue ratio and had a CFI and TLI close to and above .9 with an SRMR of below .05 and an omega of .85. Additionally, we saw limited changes in key indicators such as the CFI and RMSEA across gender, race, and sexual orientation. These findings provide evidence that the SRCS-10 is a valid and reliable assessment across gender, race, and sexual orientation.

Sections du résumé

BACKGROUND
Behavioral health care providers aim to see their clients achieve lifelong recovery from substance use disorders (SUDs). To do so, they must accurately assess incoming resources and barriers to recovery to identify areas of need for their clients. A recovery capital scale (RCS) is one way to identify these resources and barriers. However, there is limited evidence that RCSs are invariant across different demographics.
OBJECTIVES
To evaluate whether a short 10-item RCS (SRCS-10) is invariant across gender (male versus female), ethnicity (white versus African American, Hispanic, and other racial identities) and sexual orientation (heterosexual versus non-heterosexual).
METHODS
The SRCS-10 is a shortened version of White's original unpublished 35-item RCS scale that was matched on items similar to the Brief Assessment of Recovery Capital (BARC-10). We used confirmatory factor analysis (CFA) to confirm unidimensionality and then conducted measurement invariance tests.
RESULTS
This study included 2751 females (67%) and 1341 males (33%) totaling 4092 clients from six large residential treatment centers. Using both exploratory factor analysis (EFA) and CFA the SRCS-10 has a large first to second eigenvalue ratio and had a CFI and TLI close to and above .9 with an SRMR of below .05 and an omega of .85. Additionally, we saw limited changes in key indicators such as the CFI and RMSEA across gender, race, and sexual orientation.
CONCLUSIONS
These findings provide evidence that the SRCS-10 is a valid and reliable assessment across gender, race, and sexual orientation.

Identifiants

pubmed: 30668158
doi: 10.1080/00952990.2018.1558228
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-263

Auteurs

Matthew Hanauer (M)

a Centerstone Research Institute , Bloomington , IN , USA.

Kathryn Sielbeck-Mathes (K)

a Centerstone Research Institute , Bloomington , IN , USA.

Lauren Berny (L)

a Centerstone Research Institute , Bloomington , IN , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH